Cargando…
Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
Primary biliary cholangitis is an autoimmune cholestatic liver disease characterized by progressive destruction of bile ducts, which can ultimately progress to chronic liver disease and cirrhosis. Ursodeoxycholic acid and obeticholic acid are the only 2 Food and Drug Administration (FDA)-approved me...
Autores principales: | Barba Bernal, Romelia, Ferrigno, Bryan, Medina Morales, Esli, Castro, Cristina M., Goyes, Daniela, Trivedi, Hirsh, Patwardhan, Vilas R., Bonder, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Gastroenterology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081121/ https://www.ncbi.nlm.nih.gov/pubmed/36843300 http://dx.doi.org/10.5152/tjg.2023.22239 |
Ejemplares similares
-
Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis
por: Ferrigno, Bryan, et al.
Publicado: (2022) -
Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations
por: Medina-Morales, Esli, et al.
Publicado: (2023) -
Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis
por: Sierra, Leandro, et al.
Publicado: (2023) -
Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points
por: Goyes, Daniela, et al.
Publicado: (2021) -
Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases
por: Nsubuga, John Paul, et al.
Publicado: (2021)